Daptomycin for the treatment of vancomycin-resistant enterococcal bloodstream infection
博士 === 國立臺灣大學 === 臨床醫學研究所 === 106 === Linezolid, which has bacteriostatic activity, is approved for the treatment of vancomycin-resistant enterococci (VRE) infections. Daptomycin exerts bactericidal activity against VRE, but is not approved for the treatment of VRE bloodstream infection (BSI). We hy...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/8u9dvn |